Return on Equity (ROE) is 21.6. It is considered good, since it is above 15%Gross Profit Margin (GPM) is 71.0. It is considered good, since it is above 20%Operating Profit Margin (OPM) is 28.2. It is considered good, since it is above 15%Net Profit Margin (NPM) is 28.2. It is considered good, since it is above 10%Price to Earnings Growth (PEG) ratio is 0.49. It is considered under valued, since it is PEG is below 5EPS follows M (fluctuating) pattern. EPS value of the company is increasing and decreasing for every alternate quater respectively. In the last quater the EPS is increasing. Dr Reddy's Laboratories Ltd's EPS is lower than its peers.Net Profit follows M (fluctuating) pattern. Net Profit value of the company is increasing and decreasing for every alternate quater respectively. In the last quater the Net Profit is increasing.EBIT follows M (fluctuating) pattern. EBIT value of the company is increasing and decreasing for every alternate quater respectively. In the last quater the EBIT is increasing. Dr Reddy's Laboratories Ltd's EPS is greater than its peers.Revenue follows M (fluctuating) pattern. Revenue value of the company is increasing and decreasing for every alternate quater respectively. In the last quater the Revenue is increasing.The Debt-To-Equity is 0.05. As it is lower than 0.5. It is considered low or conservative.The Interest coverage ratio is 46.0. As the value is more than 1.75. It is considered good.The working capital turnover ratio of 1.905. As the value lies between 1 and 2, it is considered good.The Asset turnover is 0.8. As the value is less than 1, it is considered poor.Cash from investing activity follows M (fluctuating) pattern. Cash from investing activity value of the company is increasing and decreasing for every alternate year respectively. In the last year the Cash from investing activity is decreasing.Cash from operating activity value of the company is increasing in the last year. In the last year the Cash from operating activity is increasing.Cash from financing activity follows M (fluctuating) pattern. Cash from financing activity value of the company is increasing and decreasing for every alternate year respectively. In the last year the Cash from financing activity is decreasing. Dr Reddy's Laboratories Ltd's total assets is greater than its peers.The PE Ratio is 19.2 Since the PE_Ratio is between 10 and 20 the stock is Fair valuedThe Price to Book Ratio is 3.83 Since the price to Book Ratio is over 1 the stock is Over valuedThe Price to Sales Ratio is 3.65 Since the Price to Sales ratio is more than 1.8, the stock is OvervaluedThe Dividend yield is 0.68 Since the Dividend Yield is less than 1.0 the stock is UndervaluedThe ROCE is 26.7 Since ROCE is more than 20 it is  High PerformingThe EV/EBITDA is 11.6 Since the EV/EBITDA ratio is more than 3.0 the stock is OvervaluedThe EV/EBITDA is 11.6 Since the EV/EBITDA ratio is more than 3.0 the stock is OvervaluedThe Quick Ratio is 1.91 Since the Quick Ratio is more than 1, the stock is Financially HealthyThe Current Ratio is 2.59 Since the Current Ratio is more than 2.0 the stock is Financially Healthy